ICD Firms Urge Delay In MTWA Coverage Decision, Despite Doctors’ Support

In a new argument, Medtronic contends that CMS' proposed national decision to cover Microvolt T-Wave Alternans testing may undermine the agency's efforts to cut costs

More from Archive

More from Medtech Insight